Abstract
Accumulation of the neurotoxic amyloid β-peptide (Aβ) in the brain is a hallmark of Alzheimer’s disease (AD). Several synthetic Aβ peptides have been used to study the mechanisms of toxicity. Here, we sought to establish comparability between two commonly used Aβ peptides Aβ1-42 and Aβ25-35 on an in vitro model of Aβ toxicity. For this purpose we used organotypic slice cultures of rat hippocampus and observed that both Aβ peptides caused similar toxic effects regarding to propidium iodide uptake and caspase-3 activation. In addition, we also did not observe any effect of both peptides on Akt and PTEN phosphorylation; otherwise the phosphorylation of GSK-3β was increased. Although further studies are necessary for understanding mechanisms underlying Aβ peptide toxicity, our results provide strong evidence that Aβ1-42 and the Aβ25-35 peptides induce neural injury in a similar pattern and that Aβ25-35 is a convenient tool for the investigation of neurotoxic mechanisms involved in AD.
Similar content being viewed by others
References
Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide. Nat Mol Cell Biol 8:101–112
Parihar MS, Hemnani T (2004) Alzheimer’s disease pathogenesis and therapeutic interventions. J Clin Neurosci 11:456–467
Mattson MP, Chan SL (2003) Neuronal and glial calcium signaling in Alzheimer’s disease. Cell Calcium 34:385–397
Selkoe DJ, Schenk D (2003) Alzheimer’s disease: molecular understanding predicts amyloid-based therapeutics. Ann Rev Pharm Toxic 43:545–584
Selkoe DJ (2000) Toward a comprehensive theory for Alzheimer’s disease. Hypothesis: Alzheimer’s disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein. Ann NY Acad Sci 924:17–25
Haass C, Schlossmancher MG, Hung AY et al (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359:322–325
Shoji M, Golde TE, Ghiso J et al (1992) Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258:126–129
Selkoe DJ (1996) Amyloid beta-protein and genetics of Alzheimer’s disease. Biol Chem 271:18295–18298
Loo DT, Copani AC, Pike CJ et al (1993) Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci 90:7951–7955
Selkoe DJ (1999) Translating cell biology into therapeutics advances in Alzheimer’s disease. Nat Alerts 399:A23–A31
Bateman DA, Chakrabartty A (2004) Interactions of Alzheimer amyloid peptides with cultured cells and brain tissue, and their biological consequences. Biopolymers (Peptide Science) 76:4–14
Yankner BA, Dawes LR, Fisher S et al (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease. Science 245:417–420
Jang J-H, Surh Y-J (2005) β-Amyloid-induced apoptosis is associated with cyclooxygenase-2 up-regulation via the mitogen-activated protein kinase—NFκB signaling pathway. Free Rad Biol Med 38:1604–1613
Abe K, Saito H (2000) Amyloid β neurotoxicity not mediated the mitogen-activated protein kinase cascade in cultured rat hippocampal and cortical neurons. Neurosci Lett 292:1–4
Kubo T, Nishimura S, Kumagae Y et al (2002) In vivo conversion of Racemized_-Amyloid([D-Ser26]A_1 40) to truncated and toxic fragments ([D-Ser 26]A_25–35/40) and fragment presence in the brains of Alzheimer’s patients. J Neurosci Res 70:474–483
Clementi ME, Marini S, Coletta M et al (2005) Aβ(31-35) and Aβ(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals: role of the redox state of methionine-35. FEBS Lett 579:2913–2918
Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J et al (1995) Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 64:253–265
Misiti F, Sampaolese B, Pezzotti M et al (2005) Aβ(31-35) peptide induce apoptosis in PC 12 cells: contrast with Aβ(25-35) peptide and examination of underlying mechanisms. Neurochem Int 46:575–583
Kosuge Y, Sakikubo T, Ishige K et al (2006) Comparative study of endoplasmatic reticulum stress-induced neuronal death in rat cultured hippocampal and cerebellar granule neurons. Neurochem Int 49:285–293
Nassif M, Hoppe J, Santin K et al (2007) β-Amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3β, and PTEN. Neurochem Int 50:229–235
Cotman CW, Su JH (1996) Mechanisms of neuronal death in Alzheimer’s disease. Brain Pathol 6:493–506
Gunn-Moore FJ, Tavaré JM (1998) Apoptosis of cerebellar granule cells induced by serum withdrawal, glutamate or β-amyloid, is independent of Jun kinase or p38 mitogen activated protein kinase activation. Neurosci Lett 250:53–56
Stein-Behrens B, Adams K, Yeh M et al (1992) Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat. Neurobiol Aging 13:577–579
Malouf AT (1992) Effect of beta amyloid peptides on neurons in hippocampal slice cultures. Neurobiol Aging 13:543–551
Stoppini L, Buchs PA, Muller D (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Method 37:173–182
Bruce AJ, Malfroy B, Baudry M (1996) β-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a syntetic catalytic free radical scavenger. Proc Natl Acad Sci 93:2312–2316
Holopainen IE (2005) Organotypic hippocampal slice cultures: a model system to study basic cellular and molecular mechanisms of neuronal cell death, neuroprotection, and synaptic plasticity. Neurochem Res 30:1521–1528
Abdel-Hamid KM, Tymianski M (1997) Mechanisms and effects of intra-cellular calcium buffering on neuronal survival in organotypic hippocampal cultures exposed to anoxia/aglicemia or to excitotoxins. J Neurosci 17:3538–3553
Pringle AK, Angunawela R, Wilde GJC et al (1997) Induction of 72 KDa heat-shock protein following sub-lethal oxygen deprivation in organotypic hippocampal slice cultures. Neuropathol Appl Neurobiol 23:289–298
Valentim LM, Rodnight R, Geyer AB et al (2003) Changes in heat shock protein 27 phosphorylation and immunocontent in response to preconditioning to oxygen and glucose deprivation in organotypic hippocampal cultures. Neuroscience 118:379–386
Cimarosti H, Zamin LL, Frozza R et al (2005) Estradiol protects against oxygen and glucose deprivation in rat hippocampal organotypic cultures and activates Akt and inactivates GSK-3β. Neurochem Res 30:191–199
Horn AP, Gerhardt D, Geyer AB et al (2005) Cellular death in hippocampus in response to PI-3K pathway inhibition and oxygen and glucose deprivation. Neurochem Res 30:355–361
Ito Y, Ito M, Takagi N et al (2003) Neurotoxicity induced by amyloid beta-peptides and ibotenic acid in organotypic hippocampal cultures: protection by S-allyl-l-cystine, a garlic compound. Brain Res 985:98–107
Chong YH, Shin YJ, Lee EO et al (2006) ERK1/2 activation mediates Aβ oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 281:20315–20325
Han Y-S, Zheng W-H, Bastianetto S et al (2004) Neuroprotective effects of resveratrol against β-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharm 141:997–1005
Noraberg J, Kristensen BW, Zimmer J (1999) Markers for neuronal degeneration in organotypic slice cultures. Brain Res Prot 3:278–290
Macklis JD, Madison RD (1990) Progressive incorporation of propidium iodide in cultured mouse neurons correlates with declining electrophysiological status: a fluorescence scale of membrane integrity. J Neurosci Method 31:43–46
Peterson GL (1983) Determination of total protein. Meth Enzym 91:95–119
Baskys A, Adamchik Y (2001) Neuroprotective effects of extracellular glutamate are absent in organotypic cultures treated with the amyloid peptide Aβ(25-35). Brain Res 13:188–194
Lu XH, Bradley RJ, Dwyer DS (2004) Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38. Brain 1011:58–68
Ribe EM, Perez M, Puig B et al (2004) Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease. Brain Res Rev 47:275–289
Smith WW, Gorospe M, Kusiak JW (2006) Signaling mechanisms underlying a beta toxicity: potential therapeutic targets for Alzheimer’s disease. CNS Neurol Disord Drug Targets 5:355–361
Hsia AY, Masliah E, McConlogue L et al (1999) Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models. Proc Natl Acad Sci USA 96:3228–3233
Klein WL, Krafft GA, Finch CE (2001) Targeting small Aβ oligomers: the solution to an Alzheimer’s disease conundrum? Trends Neurosci 24:219–224
LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-β in Alzheimer’s disease. Nat Neurosci 8:499–509
Selkoe DJ (2008) Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior. Behav Brain Res. doi:10.1016/j.bbr.2008.02.016
Walsh DM, Klyubin I, Fadeeva JV et al (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539
Sáez-Valero J, de Ceballos M, Small DH et al (2002) Changes in molecular isoform distribuition of acetylcholinesterase in rat cortex and cerebrospinal fluid after intracerebroventricular administration of amyloid β-peptide. Neurosci Lett 325:199–202
Stepanichev MY, Zdobnova IM, Zarubenko II et al (2006) Studies of the effects of central administration of β-amyloid peptide (25–35): phatomorphological changes in the hippocampal and impairment of spatial memory. Neurosci Behav Physiol 36:101–106
Johansson S, Radesäter A-C, Cowburn RF et al (2006) Modelling of amyloid β-peptide induced lesions using roller-drum incubation of hippocampal slice cultures from neonatal rats. Exp Brain Res 168:11–24
Imai T, Kosuge Y, Ishige K et al (2007) Amyloid β-protein potentiates Tunicamycin-induced neuronal death in organotypic hippocampal slice cultures. Neuroscience 147:639–651
Ishige K, Takagi N, Imai T et al (2007) Role of caspase-12 in amyloid β-peptide-induced toxicity in organotypic hippocampal slices cultured for long periods. J Pharmacol Sci 104:46–55
Song X, Wu B, Takata T et al (2005) Neuroprotective effect of d-fructose-1,6-bisphosphate against β-amyloid induced neurotoxicity in rat hippocampal organotypic slice culture: involvement of PLC and MEK/ERK signaling pathways. Kobe J Med Sci 51:73–83
Suh EC, Jung YJ, Kim YA et al (2008) Aβ25-35 induces presynaptic changes in organotypic hippocampal slice cultures. Neurotoxicology. doi:101016/j.neuro.2008.04.001
Lee JN, Zipfel GJ, Choi DW (1999) The changing landscape of ischemic brain injury mechanisms. Nature 399:A7–A14
Papucci L, Formigli L, Schiavone N et al (2004) Apoptosis shifts to necrosis via intermediate types of cell death by a mechanism depending on c-myc and bcl-2 expression. Cell Tissue Res 316:197–209
Troy CM, Rabacchi SA, Friedman WJ et al (2000) Caspase-2 mediates neuronal cell death induced by β-amyloid. J Neuroscience 20:1386–1392
Stadelmann C, Deckwerth TL, Srinivasan A et al (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer’s disease. Evidence for apoptotic cell death. Am J Pathol 155:1459–1466
Jin Y, Yan E, Fan Y et al (2005) Sodium ferulate prevents amyloid-beta-induced neurotoxicity through suppression of p38 MAPK and upregulation of ERK-1/2 and Akt/protein kinase B in rat hippocampus. Acta Pharm Sin 8:943–951
Rissman RA, Poon WW, Blurton-Jones M et al (2004) Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 14:121–130
Fasulo L, Ugolini G, Cattaneo A (2005) Apoptotic effect of caspase-3 cleaved tau in hippocampal neurons and its potentiation by tau FTDP-mutaion N279K. J Alzheimers Dis 7:3–13
Perry G, Roder H, Nunomura A et al (1999) Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 10:2411–2415
Plattner F, Angelo M, Giese KP (2006) The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J Biol Chem 281:25457–25465
Li M, Wang X, Meintzer MK et al (2000) Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Mol Cell Biol 20:9356–9363
Kerr F, Rickle A, Nayeem N et al (2006) PTEN, a negative regulator of PI3 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3. FEBS Lett 580:3121–3128
Cook D, Fry MJ, Hughes K et al (1996) Wingless inactivates glycogen syntase kinase-3 via an intracellular signaling pathway which involves a protein kinase C. EMBO J 15:4526–4536
Inestrosa NC, De Ferrari GV, Garrido JL et al (2002) Wnt signaling involvement in beta-amyloid-dependent neurodegeneration. Neurochem Int 41:341–344
Hüll M, Muksch B, Akundi RS et al (2006) Amyloid beta peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes. Neurochem Int 48:663–672
Acknowledgements
This work was supported the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/Brazil), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES/Brazil), Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and Pró-Reitoria de Pesquisa da Universidade Federal do Rio Grande do Sul (PROPESQ/UFRGS). The authors thank to Alessandra Heizelmann for excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Frozza, R.L., Horn, A.P., Hoppe, J.B. et al. A Comparative Study of β-Amyloid Peptides Aβ1-42 and Aβ25-35 Toxicity in Organotypic Hippocampal Slice Cultures. Neurochem Res 34, 295–303 (2009). https://doi.org/10.1007/s11064-008-9776-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-008-9776-8